Immunome Inc.

IMNM · Nasdaq · SIC 2834: Pharmaceutical Preparations
121
SEC Filings

Business Summary

PART I Overview We are a biotechnology company committed to the development of first-in-class and best-in-class targeted oncology therapies. Our goal is to establish a broad portfolio of differentiated clinical assets to improve the lives of cancer patients. Key to that strategy is our deep expertise in the discovery, design, development, manufacturing, and ultimately commercialization of antibody-drug conjugates and other oncology therapeutics. We are advancing a pipeline that includes three cl...

Next Earnings

Q2 FY2026 — expected 2026-08-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIMNMdiscussed_in_filing Cybersecurity
topic_mentionIMNMdiscussed_in_filing Cybersecurity
topic_mentionIMNMdiscussed_in_filing Healthcare & Bio
topic_mentionIMNMdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-032025-12-310001193125-26-088172EDGAR90K words
2025-03-192024-12-310001558370-25-003302EDGAR—
2024-03-282023-12-310001558370-24-004247EDGAR—
2023-03-162022-12-310001558370-23-003964EDGAR—
2022-03-282021-12-310001558370-22-004420EDGAR—
2021-03-252020-12-310001558370-21-003493EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269603EDGAR60K words
2025-08-062025-06-300000950170-25-104035EDGAR—
2025-05-122025-03-310001558370-25-007382EDGAR—
2024-11-132024-09-300001558370-24-015524EDGAR—
2024-08-122024-06-300001558370-24-011898EDGAR—
2024-05-142024-03-310001558370-24-008066EDGAR—
2023-11-092023-09-300001558370-23-018425EDGAR—
2023-08-092023-06-300001558370-23-014090EDGAR—
2023-05-052023-03-310001558370-23-008194EDGAR—
2022-11-142022-09-300001558370-22-017574EDGAR—
2022-08-052022-06-300001558370-22-012344EDGAR—
2022-05-122022-03-310001558370-22-008432EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-030001193125-26-088141EDGAR2K words
2025-12-170001193125-25-322877EDGAR—
2025-12-150001193125-25-318429EDGAR—
2025-11-060001193125-25-269538EDGAR—
2025-08-060000950170-25-104015EDGAR—
2025-06-110001104659-25-058523EDGAR—
2025-05-120001104659-25-047304EDGAR—
2025-03-190001104659-25-025558EDGAR—
2025-01-300001104659-25-007610EDGAR—
2025-01-290001104659-25-007198EDGAR—

121 total filings indexed. 93 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001472012
TickerIMNM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ebbc55ed81522ea2d99aee2fcb4e963879472a16501fd4be48ede7ebfd27255e
parent: 11c0dc303ac5e4626698dc41102387b97668384856eb3644c649f4f5cff6a373
content hash: 4b191dd4bdca157ede8b2dd7fddfa37e3310f5ee7ac511adbbd4152b4abbc89c
signed: 2026-04-13T04:45:40.582Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf